We read with great interest the Lancet Oncology Editorial1 calling for a coordinated global approach to address the growing ...

Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?

Lenacapavir has demonstrated enormous potential as a new HIV prevention tool with a 100 per cent efficacy rate and zero ...

We are determined not to let people die,” reads a letter from the Global HIV Treatment Coalition and civil society organisations sent to the presidency and health minister Aaron Motsoaledi. The letter ...

HIV incidence in South Africa remains high, with an estimated 380 000 adults and children newly infected in 2015. 1 Because HIV-1 plasma viral load is strongly associated with sexual transmission risk ...

Nyanza became one of the regions hardest hit when HIV/Aids moved from Uganda to Kenya in the 90s, often brought by women who ...

Africa Check has debunked viral social media claims about an HIV “cure”, clarifying that the breakthrough is promising, but ...

As women benefit from focused HIV interventions, men are falling through the cracks. A bold new national campaign aims to ...

From the first reported case of AIDS to the present, what is the history of HIV-AIDS and are there parallels to the COVID-19 pandemic?

Winnie Byanyima, the executive director of the Joint United Nations Programme on HIV and AIDS, has told Bloomberg that US ...

MSF has started to roll out a new HIV prevention tool: a long-acting injectable pre-exposure prophylaxis. If we can get this drug to people at risk of HIV infection, and they accept it, this will be a ...